Schizophrenia Biomarkers: Blood Transcriptome Suggests Two Molecular Subtypes
NeuroMolecular Medicine · 2024
DOI: 10.1007/s12017-024-08817-x ↗Kurz gefasst
Fachartikel in der Zeitschrift NeuroMolecular Medicine, 2024. Verfasst von Herut Dor und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Schizophrenia, Transcriptome, Biomarkers. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tel Aviv University.
Abstract (Originalsprache)
Schizophrenia is a chronic illness that imposes a significant burden on patients, their families, and the health care system. While it has a substantial genetic component, its heterogeneous nature—both genetic and clinical—limits the ability to identify causal genes and mechanisms. In this study, we analyzed the blood transcriptomes of 398 samples (212 patients with schizophrenia and 186 controls) obtained from five public datasets. We demonstrated this heterogeneity by clustering patients with schizophrenia into two molecular subtypes using an unsupervised machine-learning algorithm. We found that the genes most influential in clustering were enriched in pathways related to the ribosome and ubiquitin-proteasomes system, which are known to be associated with schizophrenia. Based on the expression levels of these genes, we developed a logistic regression model capable of predicting schizophrenia samples in unrelated datasets with a positive predictive value of 64% ( p value = 0.039). In the future, integrating blood transcriptomics with clinical characteristics may enable the definition of distinct molecular subtypes, leading to a better understanding of schizophrenia pathophysiology and aiding in the development of personalized drugs and treatment options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
- The Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel. libi.hertzberg@gmail.com.
- Department of Physics of Complex Systems, Weizmann Institute of Science, 76100, Rehovot, Israel. libi.hertzberg@gmail.com.
- Shalvata Mental Health Center, Affiliated with the Faculty of Medicine, Tel-Aviv University, 13 Aliat Hanoar St., 45100, Hod Hasharon, Israel. libi.hertzberg@gmail.com.
Förderung
- Tel Aviv University
Zitieren
APA
Dor, H., & Hertzberg, L. (2024). Schizophrenia Biomarkers: Blood Transcriptome Suggests Two Molecular Subtypes. NeuroMolecular Medicine. https://doi.org/10.1007/s12017-024-08817-x
Vancouver
Dor H, Hertzberg L. Schizophrenia Biomarkers: Blood Transcriptome Suggests Two Molecular Subtypes. NeuroMolecular Medicine. 2024. doi:10.1007/s12017-024-08817-x
BibTeX
@article{Dor2024,
author = {Dor, Herut and Hertzberg, Libi},
title = {Schizophrenia Biomarkers: Blood Transcriptome Suggests Two Molecular Subtypes},
journal = {NeuroMolecular Medicine},
year = {2024},
doi = {10.1007/s12017-024-08817-x}
}
EUVIMED